AGL (Agilon Health) ROE % Adjusted to Book Value: 176.38% (As of Mar. 2026)


AGL Agilon Health Inc AGL
73 GF Score
Price $115.15
GF Value $94.48
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Agilon Health ROE % Adjusted to Book Value?

Agilon Health AGL -3.44% 73 ROE % Adjusted to Book Value is 176.38% as of Mar. 2026. GuruFocus rates AGL with a GF Score™ of 73/100 and a GF Value™ of $94.48 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Agilon Health's ROE % for the quarter that ended in Mar. 2026 was 126.99%. Agilon Health's PB Ratio for the quarter that ended in Mar. 2026 was 0.72. Agilon Health's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was 176.38%.

Agilon Health ROE % Adjusted to Book Value Related Terms

Agilon Health ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Agilon Health's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Agilon Health ROE % Adjusted to Book Value Chart

Agilon Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial -10.18 -1.56 -4.00 -27.67 -58.20

Agilon Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.80 -39.42 -88.08 -155.17 176.38

AGL vs MD, SEM, SGRY: ROE % Adjusted to Book Value Comparison

For the Medical Care Facilities subindustry, Agilon Health's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Agilon Health ROE % Adjusted to Book Value vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Agilon Health's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Agilon Health's ROE % Adjusted to Book Value falls into.


AGL
73GF Score
Agilon Health Inc AGL
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Agilon Health ROE % Adjusted to Book Value Calculation

Agilon Health's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-130.95% / 2.25
=-58.20%

Agilon Health's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=126.99% / 0.72
=176.38%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 176.38% mean?
Agilon Health (AGL) has a ROE % Adjusted to Book Value of 176.38% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Agilon Health and its competitors.
Is Agilon Health's ROE % Adjusted to Book Value too high?
Agilon Health's current ROE % Adjusted to Book Value is 176.38%. Overall, Agilon Health has a GF Score™ of 73/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Agilon Health's ROE % Adjusted to Book Value compare to MD and SEM?
Agilon Health's ROE % Adjusted to Book Value of 176.38% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Healthcare Providers & Services company?
A good ROE % Adjusted to Book Value depends on the Healthcare Providers & Services industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Agilon Health and its competitors. Agilon Health's current ROE % Adjusted to Book Value is 176.38%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Agilon Health stock overvalued right now?
Based on GuruFocus' analysis, Agilon Health (AGL) is currently considered Modestly Overvalued. The stock's GF Value™ is $94.48, compared to a current price of $115.15 — trading 21.9% above its estimated fair value. The current ROE % Adjusted to Book Value is 176.38%. Agilon Health's overall GF Score™ is 73/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Agilon Health (AGL), the current ROE % Adjusted to Book Value is 176.38% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Agilon Health (AGL) Overvalued in 2026?

Based on GuruFocus' analysis, Agilon Health stock appears to be overvalued. The current stock price of $115.15 is trading 21.9% above its estimated GF Value™ of $94.48. GuruFocus considers Agilon Health to be Modestly Overvalued.

Key valuation signals for AGL:

  • ROE % Adjusted to Book Value: 176.38%
  • GF Value™: $94.48 vs. price of $115.15 (21.9% above fair value)
  • GF Score™: 73/100 with 7 warning signs

No single metric tells the full story. See the AGL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Agilon Health Business Description

Address 440 Polaris Parkway, Suite 550, Westerville, OH, USA, 43082
Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients. The company provides a platform that enables physician groups to manage healthcare outcomes and costs through a Medicare-centric, capitated care model and long-term partnerships with community-based physicians.
73GF Score

Get the complete analysis for AGL

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$115.15
Price
$94.48
GF Value